NasdaqGM:MZOR

Stock Analysis Report

Executive Summary

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurgery in the United States and internationally.

Snowflake

Fundamentals

Flawless balance sheet with high growth potential.


Similar Companies

Share Price & News

How has Mazor Robotics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-0.2%

MZOR

0.7%

US Medical Equipment

-0.2%

US Market


1 Year Return

6.7%

MZOR

9.5%

US Medical Equipment

1.1%

US Market

MZOR underperformed the Medical Equipment industry which returned 11.6% over the past year.

MZOR outperformed the Market in United States of America which returned -6.5% over the past year.


Share holder returns

MZORIndustryMarket
7 Day-0.2%0.7%-0.2%
30 Day0.03%0.1%2.5%
90 Day0.1%2.5%1.6%
1 Year6.7%6.7%10.4%9.5%3.4%1.1%
3 Year458.8%458.8%69.3%64.1%45.2%35.8%
5 Year202.3%202.3%138.0%110.9%62.6%44.8%

Price Volatility Vs. Market

How volatile is Mazor Robotics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

1 year ago | Simply Wall St

Did Mazor Robotics Ltd's (NASDAQ:MZOR) Recent Earnings Growth Beat The Trend?

Valuation

Is Mazor Robotics undervalued based on future cash flows and its price relative to the stock market?

13.81x

Price to Book (PB) ratio


Intrinsic Value Based on Future Cash Flows

Mazor Robotics's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).

Mazor Robotics's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).


Price Based on Earnings

Mazor Robotics is loss making, we can't compare its value to the US Medical Equipment industry average.

Mazor Robotics is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for Mazor Robotics, we can't assess if its growth is good value.


Price Based on Value of Assets

Mazor Robotics is overvalued based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is Mazor Robotics expected to perform in the next 1 to 3 years based on estimates from 5 analysts?

114.1%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

Mazor Robotics's revenue is expected to grow significantly at over 20% yearly.

Mazor Robotics's earnings are expected to grow significantly at over 20% yearly.

Mazor Robotics's revenue growth is expected to exceed the United States of America market average.

Mazor Robotics's earnings growth is expected to exceed the United States of America market average.

Mazor Robotics's earnings growth is expected to exceed the low risk savings rate of 3%.


Earnings per Share Growth Estimates


Future Return on Equity

Unable to establish if Mazor Robotics will efficiently use shareholders’ funds in the future without estimates of Return on Equity.


Next Steps

Past Performance

How has Mazor Robotics performed over the past 5 years?

3.5%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

Mazor Robotics does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare Mazor Robotics's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare Mazor Robotics's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if Mazor Robotics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

It is difficult to establish if Mazor Robotics has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if Mazor Robotics improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is Mazor Robotics's financial position?


Financial Position Analysis

Mazor Robotics is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

Mazor Robotics's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

Mazor Robotics has no debt.

Mazor Robotics had no debt 5 years ago.


Balance Sheet

Low level of unsold assets.

Mazor Robotics has no debt, it does not need to be covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Whilst loss making Mazor Robotics has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.

Whilst loss making Mazor Robotics has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -36% per year.


Next Steps

Dividend

What is Mazor Robotics's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate Mazor Robotics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate Mazor Robotics's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as Mazor Robotics has not reported any payouts.

Unable to verify if Mazor Robotics's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as Mazor Robotics has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of Mazor Robotics's salary, the management and board of directors tenure and is there insider trading?

2.4yrs

Average management tenure


CEO

Ori Hadomi (51yo)

15.9yrs

Tenure

US$1,465,178

Compensation

Mr. Ori Hadomi has been the Chief Executive Officer of Mazor Robotics Ltd. since January 2003. Mr. Hadomi served as a Senior Financial Analyst of Intel Electronics in Israel in 1995. He joined DenX Ltd. in ...


CEO Compensation Analysis

Ori's remuneration is lower than average for companies of similar size in United States of America.

Ori's compensation has increased whilst company is loss making.


Management Age and Tenure

2.4yrs

Average Tenure

49yo

Average Age

The tenure for the Mazor Robotics management team is about average.


Board Age and Tenure

11.0yrs

Average Tenure

63yo

Average Age

The average tenure for the Mazor Robotics board of directors is over 10 years, this suggests they are a seasoned and experienced board.


Insider Trading

No 3 month insider trading information.


Ownership Breakdown


Management Team

  • Ori Hadomi (51yo)

    CEO & Director

    • Tenure: 15.9yrs
    • Compensation: US$1.47m
  • Sharon Levita (51yo)

    CFO, VP of Business Operations & Company Secretary

    • Tenure: 10.8yrs
    • Compensation: US$580.61k
  • Moshe Shoham (66yo)

    Co-Founder & CTO

    • Tenure: 17.9yrs
  • Eli Zehavi (63yo)

    Co-Founder & Executive VP of Advanced Technologies

    • Tenure: 0yrs
    • Compensation: US$579.14k
  • Doron Dinstein (47yo)

    Chief Medical Officer

    • Tenure: 6yrs
    • Compensation: US$361.56k
  • Chris Prentice (48yo)

    Chief Commercial Officer

    • Tenure: 2.4yrs
    • Compensation: US$812.43k
  • Timothy Murawski

    Vice President of Global Renaissance Business

    • Tenure: 1.3yrs
  • Inbal Azar (47yo)

    Vice President of Quality Assurance & Regulatory Affairs

    • Tenure: 2.3yrs
  • Shuki Belkar (49yo)

    Vice President of Operation & Global Service

    • Tenure: 1.3yrs
  • Oren Zarchin (41yo)

    Vice President of Product Development

    • Tenure: 1.3yrs

Board Members

  • Yuval Yanai (66yo)

    External Director

    • Tenure: 2.1yrs
  • Leon Kaplan

    Member of Advisory Board

    • Tenure: 0yrs
  • Mike Berman (60yo)

    Independent Director

    • Tenure: 4.8yrs
  • Ori Hadomi (51yo)

    CEO & Director

    • Tenure: 15.9yrs
    • Compensation: US$1.47m
  • Jonathan Adereth (71yo)

    Chairman of the Board

    • Tenure: 11yrs
    • Compensation: US$386.75k
  • Sarit Soccary Ben-Yochanan (46yo)

    Independent Director

    • Tenure: 12.2yrs
  • Gil Bianco (67yo)

    External Director

    • Tenure: 11.1yrs
  • Isador Lieberman

    Member of Advisory Board

    • Tenure: 0yrs
  • Dennis Devito

    Member of Advisory Board

    • Tenure: 0yrs

Company Information

Mazor Robotics Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Mazor Robotics Ltd.
  • Ticker: MZOR
  • Exchange: NasdaqGM
  • Founded: 2000
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: ₪6.116b
  • Listing Market Cap: ₪1.631b
  • Shares outstanding: 55.96m
  • Website: https://www.mazorrobotics.com

Number of Employees


Location

  • Mazor Robotics Ltd.
  • North Industrial Park
  • 5 Shacham Street
  • Caesarea
  • 3088900
  • Israel

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
MZORTASE (The Tel-Aviv Stock Exchange)YesOrdinary SharesILILSSep 2007
MZRT.FOTCPK (Pink Sheets LLC)YesOrdinary SharesUSUSDSep 2007
MZORNasdaqGM (Nasdaq Global Market)SPON ADS EA REPR 2 ORD ILS0.00USUSDMay 2013
M0SADB (Deutsche Boerse AG)SPON ADS EA REPR 2 ORD ILS0.00DEEURMay 2013
MZOR NBMV (Bolsa Mexicana de Valores)SPON ADS EA REPR 2 ORD ILS0.00MXMXNMay 2013

Biography

Mazor Robotics Ltd., together with its subsidiaries, engages in the development, production, and marketing of medical devices for supporting surgical procedures in the fields of orthopedics and neurosurger ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2018/12/20 00:38
End of Day Share Price2018/12/18 00:00
Earnings2018/09/30
Annual Earnings2017/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.